UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of oncology, 2015-06, Vol.26 (6), p.1175-1179

2015

Volltextzugriff (PDF)

A Randomized Phase III Trial Of Busulfan + Melphalan (Bu-Mel) Vs Melphalan Alone For Multiple Myeloma: Longer PFS In The Bu-Mel Arm

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e72-e73

2015

Volltextzugriff (PDF)

Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e72-e72

2015

Volltextzugriff (PDF)

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e295-e295

2015

Volltextzugriff (PDF)

Mononuclear cell enrichment from thawed cord blood using biosafe’s automated closed system (Sepax 2) versus the manual ficol method

Cytotherapy (Oxford, England), 2013-04, Vol.15 (4), p.S49-S49

2013

Volltextzugriff (PDF)

Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2010-04, Vol.45 (4), p.647-655

2010

Volltextzugriff (PDF)

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

Blood, 2020-03, Vol.135 (11), p.862-865

2020

Volltextzugriff (PDF)

Stem-cell transplantation in T-cell non-Hodgkin’s lymphomas

Annals of oncology, 2011-07, Vol.22 (7), p.1471-1477

2011

Volltextzugriff (PDF)

Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

Biology of blood and marrow transplantation, 2017-02, Vol.23 (2), p.285-292

2017

Volltextzugriff (PDF)

Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation

Bone marrow transplantation (Basingstoke), 2015-09, Vol.50 (9), p.1157-1167

2015

Volltextzugriff (PDF)

The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor

Gene therapy, 2011-09, Vol.18 (9), p.849-856

2011

Volltextzugriff (PDF)

Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

Annals of oncology, 2009-06, Vol.20 (6), p.1080-1085

2009

Volltextzugriff (PDF)

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients

American journal of transplantation, 2016-05, Vol.16 (5), p.1492-1502

2016

Volltextzugriff (PDF)

46-OR: High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem cell transplantation

Human immunology, 2009, Vol.70, p.S168-S168

2009

Volltextzugriff (PDF)

Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2012-12, Vol.18 (12), p.1819-1826

2012

Volltextzugriff (PDF)

Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.972-976

2014

Volltextzugriff (PDF)

Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?

Bone marrow transplantation (Basingstoke), 2015-03, Vol.50 (3), p.411-413

2015

Volltextzugriff (PDF)

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

Bone marrow transplantation (Basingstoke), 2015-04, Vol.50 (4), p.493-498

2015

Volltextzugriff (PDF)

Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice

Transplant infectious disease, 2014-12, Vol.16 (6), p.878-886

2014

Volltextzugriff (PDF)

Prognostic value of response after upfront therapy for acute GVHD

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.125-131

2012

Volltextzugriff (PDF)

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.666-670

2013

Volltextzugriff (PDF)

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

Leukemia, 2015-09, Vol.29 (9), p.1945-1948

2015

Volltextzugriff (PDF)

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1218-1223

2013

Volltextzugriff (PDF)

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.999-1001

2016

Volltextzugriff (PDF)

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.429-436

2010

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Englisch
(145)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(71)
Humans
(51)
Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Hematology
(37)
Female
(34)
Adult
(32)
Middle Aged
(32)
Male
(30)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Oncology
(28)
Transplantation
(28)
Stem Cell Transplantation
(24)
Immunology
(21)
Aged
(18)
Biophysics
(18)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(17)
Risk Factors
(17)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

A Randomized Phase III Trial Of Busulfan + Melphalan (Bu-Mel) Vs Melphalan Alone For Multiple Myeloma: Longer PFS In The Bu-Mel Arm

Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Mononuclear cell enrichment from thawed cord blood using biosafe’s automated closed system (Sepax 2) versus the manual ficol method

Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

Stem-cell transplantation in T-cell non-Hodgkin’s lymphomas

Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation

The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor

Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients

46-OR: High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem cell transplantation

Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD

Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice

Prognostic value of response after upfront therapy for acute GVHD

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT

Suchergebnisse filtern